← Browse by Condition
Medical Condition
cholangiocarcinoma
Total Trials
12
Recruiting Now
12
Trial Phases
Phase 1, Phase 2
NCT06010862 Phase 1
Recruiting
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
Enrollment
36 pts
Location
China
Sponsor
Chongqing Precision Biotech Co...
NCT05967182 Phase 2
Recruiting
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
Enrollment
24 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06260943
Recruiting
Targeted Navigation in Hepatocellular Carcinoma (HCC)
Enrollment
100 pts
Location
United States
Sponsor
University of Miami
NCT06607302
Recruiting
Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study
Enrollment
100 pts
Location
Germany
Sponsor
iOMEDICO AG
NCT02379377 Phase 1
Recruiting
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
Enrollment
110 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT03991832 Phase 2
Recruiting
Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
Enrollment
58 pts
Location
Canada
Sponsor
University Health Network, Tor...
NCT05215665
Recruiting
GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
Enrollment
146 pts
Location
China
Sponsor
Tianjin Medical University Can...
NCT05286814 Phase 2
Recruiting
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT07260175 Phase 2
Recruiting
Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
Enrollment
40 pts
Location
Germany
Sponsor
Institut für Klinische Krebsfo...
NCT04145141
Recruiting
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Enrollment
500 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04340986
Recruiting
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
Enrollment
1,250 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT06340646
Recruiting
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
Enrollment
990 pts
Location
United States
Sponsor
Washington University School o...